Noordzij M, Korevaar JC, Bos WJ, Boeschoten EW, Dekker FW, Bossuyt PM, et al. Mineral metabolism and cardiovascular morbidity and mortality risk: peritoneal dialysis patients compared with haemodialysis patients. Nephrology, dialysis, transplantation: official publication of the European Dialysis and Transplant Association -. Eur Ren Association. 2006;21(9):2513–20.

CAS  Google Scholar 

Vervloet MG, Sezer S, Massy ZA, Johansson L, Cozzolino M, Fouque D. The role of phosphate in Kidney Disease. Nat Rev Nephrol. 2017;13(1):27–38.

Article  CAS  PubMed  Google Scholar 

Kimata N, Albert JM, Akiba T, Yamazaki S, Kawaguchi T, Fukuhara S, et al. Association of mineral metabolism factors with all-cause and cardiovascular mortality in hemodialysis patients: the Japan dialysis outcomes and practice patterns study. Hemodial Int. 2007;11(3):340–8.

Article  PubMed  Google Scholar 

Tentori F, Blayney MJ, Albert JM, Gillespie BW, Kerr PG, Bommer J, et al. Mortality risk for dialysis patients with different levels of serum calcium, phosphorus, and PTH: the Dialysis outcomes and practice patterns study (DOPPS). Am J Kidney Dis. 2008;52(3):519–30.

Article  CAS  PubMed  Google Scholar 

Rivara MB, Ravel V, Kalantar-Zadeh K, Streja E, Lau WL, Nissenson AR, et al. Uncorrected and albumin-corrected calcium, Phosphorus, and mortality in patients undergoing maintenance Dialysis. J Am Soc Nephrol. 2015;26(7):1671–81.

Article  CAS  PubMed  PubMed Central  Google Scholar 

Palmer SC, Hayen A, Macaskill P, Pellegrini F, Craig JC, Elder GJ, et al. Serum levels of phosphorus, parathyroid hormone, and calcium and risks of death and Cardiovascular Disease in individuals with chronic Kidney Disease: a systematic review and meta-analysis. JAMA. 2011;305(11):1119–27.

Article  CAS  PubMed  Google Scholar 

Tentori F. Mineral and bone disorder and outcomes in hemodialysis patients: results from the DOPPS. Semin Dial. 2010;23(1):10–4.

Article  PubMed  Google Scholar 

Young EW, Albert JM, Satayathum S, Goodkin DA, Pisoni RL, Akiba T, et al. Predictors and consequences of altered mineral metabolism: the Dialysis outcomes and practice patterns study. Kidney Int. 2005;67(3):1179–87.

Article  CAS  PubMed  Google Scholar 

Fernández-Martín JL, Martínez-Camblor P, Dionisi MP, Floege J, Ketteler M, London G, et al. Improvement of mineral and bone metabolism markers is associated with better survival in haemodialysis patients: the COSMOS study. Nephrol Dial Transplant. 2015;30(9):1542–51.

Article  PubMed  Google Scholar 

Wu M, Wu H, Huang X, Ye H, Huang F, Yu X, et al. Associations between serum mineral metabolism parameters and mortality in patients on peritoneal dialysis. Nephrol (Carlton). 2019;24(11):1148–56.

Article  CAS  Google Scholar 

Liu X, Huang R, Wu H, Wu J, Wang J, Yu X, et al. Patient characteristics and risk factors of early and late death in incident peritoneal dialysis patients. Sci Rep. 2016;6:32359.

Article  CAS  PubMed  PubMed Central  Google Scholar 

Noordzij M, Korevaar JC, Boeschoten EW, Dekker FW, Bos WJ, Krediet RT. The Kidney Disease outcomes Quality Initiative (K/DOQI) Guideline for Bone Metabolism and Disease in CKD: association with mortality in dialysis patients. Am J Kidney Diseases: Official J Natl Kidney Foundation. 2005;46(5):925–32.

Article  Google Scholar 

Chuang SH, Wong HC, Vathsala A, Lee E, How PP. Prevalence of chronic kidney disease-mineral and bone disorder in incident peritoneal dialysis patients and its association with short-term outcomes. Singap Med J. 2016;57(11):603–9.

Article  Google Scholar 

Huang N, Li H, Fan L, Zhou Q, Fu D, Guo L, et al. Serum phosphorus and albumin in patients undergoing peritoneal Dialysis: Interaction and Association with Mortality. Front Med (Lausanne). 2021;8:760394.

Article  PubMed  Google Scholar 

Noordzij M, Korevaar JC, Dekker FW, Boeschoten EW, Bos WJ, Krediet RT, et al. Mineral metabolism and mortality in dialysis patients: a reassessment of the K/DOQI guideline. Blood Purif. 2008;26(3):231–7.

Article  CAS  PubMed  Google Scholar 

Phelan PJ, O’Kelly P, Walshe JJ, Conlon PJ. The importance of serum albumin and phosphorous as predictors of mortality in ESRD patients. Ren Fail. 2008;30(4):423–9.

Article  CAS  PubMed  Google Scholar 

Kang SH, Cho KH, Park JW, Yoon KW, Do JY. Risk factors for mortality in stable peritoneal dialysis patients. Ren Fail. 2012;34(2):149–54.

Article  CAS  PubMed  Google Scholar 

Liu CT, Lin YC, Lin YC, Kao CC, Chen HH, Hsu CC, et al. Roles of serum calcium, phosphorus, PTH and ALP on Mortality in Peritoneal Dialysis patients: a Nationwide, Population-based Longitudinal Study using TWRDS 2005–2012. Sci Rep. 2017;7(1):33.

Article  PubMed  PubMed Central  Google Scholar 

Chen L, Tang X, Zheng H, Wang H, Xia P, Wang Y, et al. Optimal targets of chronic kidney disease-mineral and bone disorder markers for Chinese patients with maintenance peritoneal dialysis: a single-center retrospective cohort study. Ren Fail. 2022;44(1):336–45.

Article  CAS  PubMed  PubMed Central  Google Scholar 

Battelino T, Danne T, Bergenstal RM, Amiel SA, Beck R, Biester T, et al. Clinical targets for continuous glucose Monitoring Data Interpretation: recommendations from the International Consensus on Time in Range. Diabetes Care. 2019;42(8):1593–603.

Article  PubMed  PubMed Central  Google Scholar 

Danese MD, Belozeroff V, Smirnakis K, Rothman KJ. Consistent control of mineral and bone disorder in incident hemodialysis patients. Clin J Am Soc Nephrology: CJASN. 2008;3(5):1423–9.

Article  Google Scholar 

Tangri N, Wagner M, Griffith JL, Miskulin DC, Hodsman A, Ansell D, et al. Effect of bone mineral guideline target achievement on mortality in incident dialysis patients: an analysis of the United Kingdom Renal Registry. Am J Kidney Diseases: Official J Natl Kidney Foundation. 2011;57(3):415–21.

Article  Google Scholar 

Yu J, Xia X, Lin T, Huang N, Qiu Y, Yang X, et al. Non-high-density lipoprotein cholesterol and mortality among peritoneal dialysis patients. J Clin Lipidol. 2021;15(5):732–42.

Article  PubMed  Google Scholar 

Liu R, Peng Y, Wu H, Diao X, Ye H, Huang X, et al. Uric acid to high-density lipoprotein cholesterol ratio predicts cardiovascular mortality in patients on peritoneal dialysis. Nutr Metab Cardiovasc Dis. 2021;31(2):561–9.

Article  CAS  PubMed  Google Scholar 

Gong N, Xiao Z, Zhang F, Zhong X, He Y, Yi Z, et al. Duration of Serum Phosphorus Control Associated with overall mortality in patients undergoing peritoneal Dialysis. Kidney Dis (Basel). 2020;6(6):434–43.

Article  PubMed  Google Scholar 

Li PK, Chow KM, Van de Luijtgaarden MW, Johnson DW, Jager KJ, Mehrotra R, et al. Changes in the worldwide epidemiology of peritoneal dialysis. Nat Rev Nephrol. 2017;13(2):90–103.

Article  CAS  PubMed  Google Scholar 

Yu X, Chen J, Ni Z, Chen N, Chen M, Dong J, et al. Number of daily peritoneal Dialysis exchanges and mortality risk in a Chinese Population. Perit Dial Int. 2018;38(Suppl 2):53–S63.

Article  Google Scholar 

K/DOQI clinical. Practice guidelines for bone metabolism and Disease in chronic Kidney Disease. Am J Kidney Diseases: Official J Natl Kidney Foundation. 2003;42(4 Suppl 3):1–201.

Google Scholar 

NKF-DOQI clinical practice guidelines for peritoneal dialysis adequacy. Natl Kidney Foundation Am J Kidney Dis. 1997;30(3 Suppl 2):67–136.

Google Scholar 

Noordzij M, Korevaar JC, Boeschoten EW, Dekker FW, Bos WJ, Krediet RT, et al. The Kidney Disease outcomes Quality Initiative (K/DOQI) Guideline for Bone Metabolism and Disease in CKD: association with mortality in dialysis patients. Am J Kidney Dis. 2005;46(5):925–32.

Article  PubMed  Google Scholar 

Ketteler M, Block GA, Evenepoel P, Fukagawa M, Herzog CA, McCann L, et al. Executive summary of the 2017 KDIGO chronic kidney Disease-Mineral and Bone Disorder (CKD-MBD) Guideline Update: what’s changed and why it matters. Kidney Int. 2017;92(1):26–36.

Article  PubMed  Google Scholar 

Mehrotra R, Devuyst O, Davies SJ, Johnson DW. The current state of peritoneal Dialysis. J Am Soc Nephrology: JASN. 2016;27(11):3238–52.

Article  CAS  PubMed  PubMed Central  Google Scholar 

Lee JE, Lim JH, Jang HM, Kim YS, Kang SW, Yang CW, et al. Low serum phosphate as an Independent predictor of increased infection-related mortality in dialysis patients: a prospective multicenter cohort study. PLoS ONE. 2017;12(10):e0185853.

Article  PubMed  PubMed Central  Google Scholar 

Paniagua R, Ventura MD, Ávila-Díaz M, Hinojosa-Heredia H, Méndez-Duran A, Cisneros A, et al. Reaching targets for mineral metabolism clinical practice guidelines and its impact on outcomes among Mexican chronic dialysis patients. Arch Med Res. 2013;44(3):229–34.

Article  CAS  PubMed  Google Scholar 

KDIGO clinical practice guideline for the. Diagnosis, evaluation, prevention, and treatment of chronic kidney Disease-Mineral and Bone Disorder (CKD-MBD). Kidney Int Supplement. 2009(113):S1–130.

Truyts C, Custodio M, Pecoit-Filho R, Moraes TP, Jorgetti V. Cardiovascular mortality in peritoneal dialysis: the impact of mineral disorders. J Bras Nefrol. 2021;43(2):182–90.

Article  PubMed  PubMed Central  Google Scholar